Related Experiment Video

Updated: Mar 10, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.3K

Bacterial pneumonia as an influenza complication

Ignacio Martin-Loeches1, Frank van Someren Gréve, Marcus J Schultz

  • 1aMultidisciplinary Intensive Care Research Organization (MICRO) bDepartment of Clinical Medicine, Trinity Centre for Health Sciences, Trinity College Dublin (TCD), St James's University Hospitals, Dublin, Ireland cDepartment of Intensive Care dDepartment of Medical Microbiology eLaboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, the Netherlands.

Current Opinion in Infectious Diseases
|December 17, 2016
PubMed
Abstract

Insights

Bacterial coinfection is a frequent complication of influenza, especially in critically ill patients. Streptococcus pneumoniae is the most common pathogen, and evolving resistance patterns require attention during current outbreaks.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Epidemiology

Background:

  • Influenza coinfection, particularly bacterial coinfection, pathogenesis and impact remain incompletely understood.
  • Bacterial pneumonia is a significant complication of influenza virus infection.
  • Understanding coinfection dynamics is crucial for managing influenza outbreaks.

Purpose of the Study:

  • To review and summarize studies on bacterial coinfection during recent pandemic influenza outbreaks.
  • To elucidate the role of systemic immune mechanisms in influenza-bacterial coinfection.
  • To analyze the changing epidemiology of coinfection over time.

Main Methods:

  • Literature review of studies on bacterial coinfection in influenza.
  • Analysis of point prevalence data for bacterial coinfection in influenza patients.
  • Examination of pathogen frequency and antimicrobial resistance trends.

Main Results:

  • Bacterial coinfection is frequent, particularly in critically ill influenza patients.
  • Streptococcus pneumoniae is the most common bacterial pathogen identified.
  • Increasing rates of potentially resistant pathogens have been observed over the years.
  • Systemic immune mechanisms are key to coinfection development.

Conclusions:

  • Bacterial pneumonia is a confirmed influenza complication.
  • Recent epidemiological findings clarify pathogen contributions to coinfection.
  • Immunosuppression is a risk factor for bacterial coinfection in influenza.
  • Evolving coinfection epidemiology necessitates updated management strategies for current outbreaks.

More Related Videos

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

17.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.2K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
991
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K